Feedback / Questions
IPH6501 - Innate
https://www.businesswire.com/news/home/20250612105785/en/Innate-Pharma-Highlights-Preclinical-Antitumor-Activity-of-IPH6501-in-Diffuse-Large-B-Cell-Lymphoma-and-Follicular-Lymphoma-at-the-2025-European-Hematology-Association-EHA-Congress
Jun 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next